Search

Your search keyword '"Sevrain, M."' showing total 22 results
Start Over Author "Sevrain, M."
22 results on '"Sevrain, M."'

6. The wide POLG-related spectrum: An integrated view

Author

Béreau, M., primary, Anheim, M., additional, Echaniz-Laguna, A., additional, Magot, A., additional, Verny, C., additional, Goideau-Sevrain, M., additional, Barth, M., additional, Amati-Bonneau, P., additional, Allouche, S., additional, Ayrignac, X., additional, Bédat-Millet, A.-L., additional, Guyant-Maréchal, L., additional, Kuntzer, T., additional, Ochsner, F., additional, Petiot, P., additional, Vial, C., additional, Omer, S., additional, Sole, G., additional, Taieb, G., additional, Carvalho, N., additional, Tio, G., additional, Kremer, S., additional, Acquaviva-Bourdain, C., additional, de Camaret, B. Mousson, additional, and Tranchant, C., additional

Published
2016
Full Text
View/download PDF

9. Quels sont les facteurs de risque du rhumatisme psoriasique ? Analyse systématique de la littérature

Author

Rouzaud, M., primary, Sevrain, M., additional, Villani, A., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Jullien, D., additional, Misery, L., additional, Aractingi, S., additional, Aubin, F., additional, Joly, P., additional, Le Maitre, M., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Beylot-Barry, M., additional

Published
2013
Full Text
View/download PDF

10. Comment dépister un rhumatisme psoriasique : revue systématique et méta-analyse des questionnaires

Author

Villani, A.-P., primary, Rouzaud, M., additional, Sevrain, M., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Beylot-Barry, M., additional, Misery, L., additional, Joly, P., additional, Le Maître, M., additional, Aractingi, S., additional, Aubin, F., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Jullien, D., additional

Published
2013
Full Text
View/download PDF

12. Prise en charge du psoriasis pustuleux palmoplantaire (PPPP) : analyse systématique de la littérature

Author

Sevrain, M., primary, Villani, A., additional, Rouzaud, M., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Beylot-Barry, M., additional, Jullien, D., additional, Aractingi, S., additional, Aubin, F., additional, Joly, P., additional, Le Maitre, M., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Misery, L., additional

Published
2013
Full Text
View/download PDF

13. Existe-t-il des examens d’imagerie utiles au dermatologue pour le diagnostic de rhumatisme psoriasique ? Analyse systématique de la littérature

Author

Sevrain, M., primary, Villani, A., additional, Rouzaud, M., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Beylot-Barry, M., additional, Jullien, D., additional, Aractingi, S., additional, Aubin, F., additional, Joly, P., additional, Le Maitre, M., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Misery, L., additional

Published
2013
Full Text
View/download PDF

14. Peut-on définir un phénotype cutané du psoriasis à risque de rhumatisme psoriasique?

Author

Rouzaud, M., primary, Sevrain, M., additional, Villani, A., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Jullien, D., additional, Misery, L., additional, Aractingi, S., additional, Aubin, F., additional, Joly, P., additional, Le Maitre, M., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Beylot-Barry, M., additional

Published
2013
Full Text
View/download PDF

15. Prévalence des rhumatismes psoriasiques non diagnostiqués chez les patients atteints de psoriasis cutanés

Author

Villani, A.-P., primary, Rouzaud, M., additional, Sevrain, M., additional, Barnetche, T., additional, Paul, C., additional, Misery, L., additional, Richard, M.-A., additional, Beylot-Barry, M., additional, Joly, P., additional, Le Maître, M., additional, Aractingi, S., additional, Aubin, F., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Jullien, D., additional

Published
2013
Full Text
View/download PDF

16. Traitement du rhumatisme psoriasique (hors biothérapie) : évaluation de la qualité méthodologique des recommandations internationales

Author

Sevrain, M., primary, Villani, A., additional, Rouzaud, M., additional, Barnetche, T., additional, Paul, C., additional, Richard, M.-A., additional, Beylot-Barry, M., additional, Jullien, D., additional, Aractingi, S., additional, Aubin, F., additional, Joly, P., additional, Le Maitre, M., additional, Cantagrel, A., additional, Ortonne, J.-P., additional, and Misery, L., additional

Published
2013
Full Text
View/download PDF

19. Syndrome DRESS-like dû au shiitake

Author

Sevrain, M., primary, Talour, K., additional, Abasq, C., additional, Sassolas, B., additional, Le Ru, Y., additional, Jannou, V., additional, and Misery, L., additional

Published
2011
Full Text
View/download PDF

21. Primary Burning Mouth Syndrome: A Questionnaire Study of Neuropathic and Psychological Components.

Author

Sevrain M, Brenaut E, Le Toux G, and Misery L

Subjects
Aged, Anxiety epidemiology, Depression epidemiology, Female, Humans, Male, Middle Aged, Neuralgia epidemiology, Pain Measurement methods, Surveys and Questionnaires, Anxiety physiopathology, Burning Mouth Syndrome physiopathology, Burning Mouth Syndrome psychology, Depression physiopathology, Neuralgia physiopathology
Abstract

Background: The pathophysiology of primary burning mouth syndrome (BMS) is extensively debated but poorly understood., Objective: The aim of the study was to evaluate neuropathic and psychological components of BMS in patients with primary BMS., Methods: Subjects were recruited through a consultation dedicated to mouth diseases, during which a diagnosis of primary BMS was assessed. Patients answered the abbreviated Douleur Neuropathique 4 questionnaire (DN4i), the Hospital Anxiety and Depression Scale (HADS) and the questionnaire de la douleur de Saint-Antoine (QDSA), the French version of the McGill pain questionnaire., Results: Thirty-five patients with primary BMS were included in the study: 31 % of them had a DN4i score in favour of neuropathic pain and 34.3 % had a HADS overall score in favour of anxiety and depressive disorder., Conclusion: Both physiological and psychological aspects of BMS need to be actively investigated by clinicians to successfully manage these patients. The physiological and psychological aspects are not mutually exclusive. The DN4i and the HADS are easy-to-use tools and could be used in an initial assessment of BMS patients.

Published
2016
Full Text
View/download PDF

22. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.

Author

Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M, Aractingi S, Aubin F, Cantagrel A, Ortonne JP, and Jullien D

Subjects
Comorbidity, Delayed Diagnosis, Female, France epidemiology, Humans, Male, Needs Assessment, Prevalence, Risk Assessment, Arthritis, Psoriatic diagnosis, Arthritis, Psoriatic epidemiology, Psoriasis epidemiology
Abstract

Background: Skin psoriasis precedes the onset of psoriatic arthritis (PsA) in 84% of patients with psoriasis. Dermatologists have an important role to screen psoriasis patients for PsA. The efficiency of PsA screening remains unknown., Objective: We sought to determine the point prevalence of undiagnosed PsA in patients with psoriasis using a systematic search of the literature and meta-analysis., Methods: PubMed, Cochrane, and Embase database searches yielded 394 studies for review. No study aimed to determine the prevalence of undiagnosed PsA in patients with psoriasis. We assumed that the prevalence of newly diagnosed PsA in patients with psoriasis at the time they seek medical care could be a sound estimate of this value. Seven epidemiological studies and 5 studies on PsA screening questionnaires allowed us to clearly identify patients with newly diagnosed PsA and were selected for review., Results: The prevalence of undiagnosed PsA was 15.5% when all studies were considered and 10.1% when only epidemiological studies were considered., Limitations: Data were obtained from studies not designed to address the question at hand. Heterogeneity was high (I(2) = 96.86%), and therefore a random effects model was used., Conclusion: The high prevalence of undiagnosed PsA in patients with psoriasis adds to the recommendation that dermatologists need to screen all patients with psoriasis for PsA., (Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results